Physician profile
Ruchir P Patel
NPI 1538351416
$374,487.86
in general payments reported to CMS, 2019-2025
19 companies · $157K in 2025
The $157K reported for 2025 was more than what 99% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2020: $9,668 · 2021: $5,089 · 2022: $39K · 2023: $91K · 2024: $72K · 2025: $157K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $194K · Travel and Lodging: $50K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Honoraria: $24K · Food and Beverage: $9,507 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $9,000 · Education: $39.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $193,667.33 |
| Travel and Lodging | $50,365.01 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,750.00 |
| Honoraria | $24,000.00 |
| Food and Beverage | $9,506.84 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $9,000.00 |
| Education | $39.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $300,037.47 | 2019-2025 | Inspire |
| Lilly USA, LLC | $47,998.31 | 2024-2025 | Mounjaro, Zepbound |
| Zoll Respicardia, INC. | $14,807.81 | 2023-2025 | Remede System |
| Eisai INC. | $7,571.64 | 2020-2021 | |
| Itamar Medical INC | $1,607.98 | 2021-2024 | Watchpatone |
| Eli Lilly and Company | $1,350.00 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $224.52 | 2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $164.34 | 2023 | Spravato |
| Jazz Pharmaceuticals INC. | $156.33 | 2019-2021 | |
| Watermark Medical, INC. | $130.74 | 2022 | |
| Idorsia Pharmaceuticals US INC | $124.97 | 2022 | |
| Philips North America LLC | $74.63 | 2019 | |
| 3b Medical, INC. | $64.30 | 2025 | Luna |
| Ucb, INC. | $53.56 | 2021-2024 | Fintepla |
| Fisher & Paykel Healthcare INC | $37.83 | 2025 | Fisher & Paykel Healthcare |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $37.49 | 2019-2021 | |
| Allergan, INC. | $24.63 | 2020 | |
| Vanda Pharmaceuticals INC. | $21.31 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruchir Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.